202 related articles for article (PubMed ID: 19562944)
1. [Strategy for development of imaging biomarkers].
Ishiwata K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
Mazière B; Delforge J
Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.
Leopoldo M; Lacivita E; De Giorgio P; Contino M; Berardi F; Perrone R
Bioorg Med Chem; 2009 Jan; 17(2):758-66. PubMed ID: 19081257
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceuticals: molecular imaging using positron emission tomography.
Antoni G; Långström B
Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
[TBL] [Abstract][Full Text] [Related]
5. The use of imaging in preclinical drug development.
Vanderheyden JL
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):374-81. PubMed ID: 19834446
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptor ligands and PET imaging of the CNS.
Bauer A; Ishiwata K
Handb Exp Pharmacol; 2009; (193):617-42. PubMed ID: 19639295
[TBL] [Abstract][Full Text] [Related]
7. Using positron emission tomography to facilitate CNS drug development.
Lee CM; Farde L
Trends Pharmacol Sci; 2006 Jun; 27(6):310-6. PubMed ID: 16678917
[TBL] [Abstract][Full Text] [Related]
8. Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET.
Colabufo NA; Berardi F; Contino M; Fazio F; Matarrese M; Moresco RM; Niso M; Perrone R; Tortorella V
J Pharm Pharmacol; 2005 Nov; 57(11):1453-9. PubMed ID: 16259778
[TBL] [Abstract][Full Text] [Related]
9. Molecular tracers for the PET and SPECT imaging of disease.
Pimlott SL; Sutherland A
Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging targeting peptide receptors.
Schottelius M; Wester HJ
Methods; 2009 Jun; 48(2):161-77. PubMed ID: 19324088
[TBL] [Abstract][Full Text] [Related]
11. Applications of neuroreceptor imaging to psychiatry research.
Smith GS; Koppel J; Goldberg S
Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel fluoro and iodo quinoline carboxamides as potential ligands of NK-3 receptors for in vivo imaging studies.
Bennacef I; Tymciu S; Dhilly M; Lasne MC; Debruyne D; Perrio C; Barré L
Bioorg Med Chem; 2004 Aug; 12(16):4533-41. PubMed ID: 15265501
[TBL] [Abstract][Full Text] [Related]
13. [Neurotransmitter-receptor-imaging].
Cordes M; Hierholzer J; Nikolai-Beyer K
Radiologe; 1993 Nov; 33(11):612-9. PubMed ID: 7904078
[TBL] [Abstract][Full Text] [Related]
14. Role of in vivo imaging of the central nervous system for developing novel drugs.
Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective neuroimaging in vivo.
Smith DF; Jakobsen S
Eur Neuropsychopharmacol; 2007 Jul; 17(8):507-22. PubMed ID: 17368004
[TBL] [Abstract][Full Text] [Related]
16. Ab initio computational study of positron emission tomography ligands interacting with lipid molecule for the prediction of nonspecific binding.
Rosso L; Gee AD; Gould IR
J Comput Chem; 2008 Nov; 29(14):2397-405. PubMed ID: 18442082
[TBL] [Abstract][Full Text] [Related]
17. Radiopharmaceutical pharmacokinetics in animals: critical considerations.
Giron MC
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):359-64. PubMed ID: 19834444
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging with SPECT as a tool for drug development.
Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
[TBL] [Abstract][Full Text] [Related]
20. The role of molecular imaging in drug discovery and development.
Hargreaves RJ
Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
